Does Premera cover Zepbound? Only if your employer chose to add weight-loss drug coverage. Premera Blue Cross covers weight-management GLP-1s like Zepbound only for employer groups that elected the benefit, and then only with prior authorization. If your group didn't add it, Zepbound for weight loss isn't covered, and Premera's Washington individual plans don't list it.
Below we cover how to tell whether your Premera plan has the benefit, which Premera drug lists include Zepbound for 2027, Premera's 2026 prior authorization rules, the sleep apnea route, and what Zepbound costs if you pay cash.
Quick answer by Premera plan type
| Your plan | Zepbound for weight loss | Zepbound for sleep apnea | Your best next step |
|---|---|---|---|
| Employer plan that added weight-loss drug coverage | Covered with prior authorization | Ask Premera; separate criteria exist | Ask your doctor to request prior authorization |
| Employer plan without the benefit | Not covered | Ask Premera | Cash pay, or ask HR about adding it |
| Washington individual and family plan | Not on the 2026 or 2027 drug lists | Not on the 2026 or 2027 drug lists | Cash pay |
| Medicare | Through Medicare's GLP-1 Bridge if eligible | Not through the Bridge | Ask your doctor about the Bridge |
If you're not sure which route is yours, The RX Index's free quiz can sort it out in about two minutes.
Find your GLP-1 path in 2 minutes
How Premera decides Zepbound coverage
Premera splits GLP-1 coverage into two pathways (Premera Formulary Newsletter, February 2026):
- GLP-1s for type 2 diabetes are covered across all plans, with a documented type 2 diabetes diagnosis and medical necessity criteria. Zepbound isn't a diabetes drug, so this path doesn't apply to it. The tirzepatide product for diabetes is Mounjaro.
- GLP-1s for weight management, including Wegovy and Zepbound, are covered only when an employer group has elected this benefit. Those groups get prior authorization, clinical criteria, dose checks and quantity limits. "If a group does not elect weight-loss drug coverage, GLP-1s for obesity are not covered."
Premera's weight-management policy says the same thing in plainer terms: "Drugs for weight management are excluded under many benefit plans" (Premera Pharmacy Policy 5.01.621, effective September 1, 2026).
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
How to tell if your employer added the benefit
Premera can't approve Zepbound for weight loss if your plan excludes it, no matter how well you meet the medical criteria. So check the benefit first:
- Look in your benefit booklet for "weight loss drugs," "drugs for weight management" or "anti-obesity medications."
- Call the customer service number on your Premera card and ask: "Does my plan cover drugs for weight management, and does it cover Zepbound?"
- Ask HR or your benefits team whether the company elected weight-loss drug coverage for this plan year.
Premera's policy also warns that some plans cover weight-loss GLP-1s only above a set BMI, and that threshold may differ from the medical criteria below. Your benefit booklet or customer service can tell you if yours has one.
Which Premera drug lists include Zepbound
Your drug list name, such as B3 or E1/E4, is printed on the front of your Premera ID card as your Rx formulary. We searched every 2027 Premera drug list for Zepbound. Most employer lists include it, but always with an OPT flag, which Premera defines as an optional benefit: "Many health plans exclude drugs for erectile dysfunction (ED), fertility, and weight management." So a listing on your drug list doesn't mean your employer bought the benefit.
| Premera drug list (Rx formulary on your ID card) | Zepbound pen and KwikPen on the 2027 list | Restrictions shown | What it means for you |
|---|---|---|---|
| A1/A2 (Open and Preferred plans) | Listed, Brand tier on A2 | PA, QL, OPT | Covered only if your employer added weight-loss drugs, then with prior authorization |
| B3 and B4 (Preferred plans) | Listed, Non-preferred brand tier (3) | PA, OPT, QL | Same: employer benefit first, then prior authorization |
| E1/E4 and E6 (Essentials plans) | Listed, tier 4 | PA, QL, OPT | Same: employer benefit first, then prior authorization |
| E1/E3 (Essentials plans) | Listed as non-formulary (NF) | PA, QL | Not on the formulary; ask Premera customer service about a formulary exception |
| S1/S6 (Summit plans) | Not listed | n/a | Zepbound isn't on this list |
| Individual plans (M1, M2, M4) | Not listed | n/a | Cash pay, or the Medicare Bridge if you're eligible |
Quantity limits on these lists match the policy: 4 single-dose pens per 28 days, or 1 KwikPen per 28 days. The 2026 versions of the A1/A2, B3, B4, E1/E3 and E1/E4 lists (effective November 1, 2026) list Zepbound on the same tiers, and each one carries the OPT flag. Premera's 2026 M1 and M4 lists for employer Balance and Choice metallic plans don't list Zepbound. Sources: Premera's 2027 employer drug lists, checked November 20, 2026.
Premera individual plans
All of Premera's Washington individual and family plans are EPO plans. In 2026 they use the M4 drug list, except the Preferred Bronze HSA plan, which uses M2 (Premera 2026 individual plan letter guide). Neither list includes Zepbound or Wegovy. The 2026 M4 list (effective November 1, 2026) includes Mounjaro with prior authorization, which is for type 2 diabetes (Premera 2026 Metallic M4 drug list; Premera 2026 Metallic M2 drug list).
Nothing changes for 2027. Premera's 2027 individual drug lists, M4 and M1 (effective January 1, 2027), also leave out Zepbound and Wegovy (Premera 2027 Metallic M4 drug list). So if you're shopping Premera individual plans during open enrollment for 2027, plan on paying cash for Zepbound for weight loss. We didn't check Premera's Alaska individual drug lists.
Premera Zepbound prior authorization rules
If your plan includes the benefit, Premera reviews Zepbound under Pharmacy Policy 5.01.621, Drugs for Weight Management (effective September 1, 2026, last revised August 11, 2026).
For chronic weight management
| Requirement | What Premera asks for |
|---|---|
| Age | 18 or older |
| Lifestyle trial | At least 3 months of behavior changes and a reduced-calorie diet |
| Weight | BMI of 30 or higher, or 27 or higher with at least one listed condition |
| Listed conditions | Asthma, heart disease, COPD, coronary artery disease, high cholesterol or triglycerides, high blood pressure, knee osteoarthritis, fatty liver disease, sleep apnea, polyendocrine metabolic ovarian syndrome (PMOS), or type 2 diabetes |
| Use | Alongside a reduced-calorie diet and more physical activity |
| Dose | Up to 15 mg once a week |
| Quantity | 4 single-dose pens or vials per 28 days, or 1 KwikPen or multi-dose vial per 28 days |
| Other drugs | Not combined with other weight-loss drugs, such as Wegovy, Saxenda, Foundayo, Contrave or phentermine |
| First approval | 7 months |
The quantity rule names both the single-dose pen and the KwikPen, so the policy allows either form. Your plan's drug list may still prefer one.
Renewal after 7 months
Premera's renewal approvals run for 1 year when your records show:
- At least 5% loss from your starting weight after 7 months of treatment
- You tolerate a Zepbound maintenance dose of up to 15 mg once a week
- You're still following a reduced-calorie diet and more physical activity
If you haven't reached 5% by month 7, renewal may be denied. Keep your starting weight on record and make sure your doctor documents your progress.
What your doctor's office should send
Premera's policy says the medical records should include office visit notes with your baseline weight, BMI, relevant history including any weight-related conditions, your diet plan, your activity plan and your medication dose. Our GLP-1 prior authorization documents checklist lists what to gather. For other Blue plans, see Blue Cross Zepbound prior authorization.
If your Premera plan may cover Zepbound, Ro can check your benefits and handle the prior authorization for the auto-injector pen. Ro's insurance help covers the Wegovy pen, the Zepbound auto-injector pen and Ozempic, and Ro says prior authorization usually takes about 1 to 2 weeks. Insurance doesn't pay Ro's membership fee (Ro insurance page, checked November 20, 2026).
Check whether your Premera plan covers Zepbound (sponsored affiliate link, opens in a new tab)
If Premera approves Zepbound
Lilly's savings card can lower your copay. Lilly says people with commercial insurance that covers Zepbound may pay as little as $25 for a 1-month or 3-month supply of Zepbound single-dose pens. Government plans are excluded (Lilly Zepbound cost information). More in our Zepbound savings card guide and Zepbound cost with insurance.
Does Premera cover Zepbound for sleep apnea?
Zepbound is FDA-approved for chronic weight management in adults with obesity, or overweight with a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity (Zepbound prescribing information, revised November 2026).
Premera's policy has separate sleep apnea criteria:
| Requirement | What Premera asks for |
|---|---|
| Age | 18 or older |
| Weight | BMI of 30 or higher |
| Sleep study | Within the past 12 months, showing at least 15 breathing events per hour (AHI of 15 or more) |
| Exclusions | Not for central sleep apnea (50% or more central events) or Cheyne-Stokes breathing |
| Use | Alongside a reduced-calorie diet and more physical activity |
| Dose and quantity | Same limits as for weight management |
| First approval | 12 months |
| Renewal | At least 10% loss from your starting weight after 12 months, stable sleep apnea symptoms, and continued diet and activity |
Premera's exclusion note talks about Zepbound "for weight management," so a sleep apnea request may be reviewed differently. Your plan's benefits still decide. Ask Premera whether your plan covers Zepbound for sleep apnea, and bring your sleep study results. More in does insurance cover Zepbound for sleep apnea.
What Zepbound costs if Premera won't cover it
If your employer didn't add the benefit, or you're on an individual plan, Zepbound for weight loss means paying cash.
On Ro's pricing page, the Zepbound KwikPen is cash-pay only: $299 a month at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg through 15 mg with the manufacturer offer. Ro shows that offer as $50 off at 7.5 mg and $150 off at 10 to 15 mg. Ro says its cash prices match LillyDirect, NovoCare and TrumpRx. The Ro membership is extra: $39 the first month (refunded if you're not eligible), then $74 to $149 a month depending on plan length. The $74 rate is on a 12-month plan paid upfront (Ro pricing, checked November 20, 2026).
Your first-year cash cost for Zepbound through Ro
This is the whole receipt, not only the sticker price. It assumes one dose step per month up to 7.5 mg, which is a common pattern but not a dosing plan. Your prescriber decides your dose.
| Month | Zepbound KwikPen dose (example) | Medication | Ro membership (monthly plan) | Total that month |
|---|---|---|---|---|
| 1 | 2.5 mg | $299 | $39 | $338 |
| 2 | 5 mg | $399 | $149 | $548 |
| 3–12 | 7.5 mg or higher | $449 × 10 = $4,490 | $149 × 10 = $1,490 | $598 a month ($5,980) |
| Year one | $5,188 | $1,678 | $6,866 |
With Ro's 12-month plan paid upfront, membership is as low as $74 a month ($888 due at once), which lowers the yearly membership cost. Math by The RX Index from Ro's listed prices on November 20, 2026. Prices can change.
Lilly's Zepbound savings card won't help if your plan excludes Zepbound. It requires commercial insurance that covers Zepbound.
Other cash routes to compare: the cheapest Zepbound without insurance and how to get the Zepbound KwikPen online.
See Ro's Zepbound KwikPen cash prices (sponsored affiliate link, opens in a new tab)
If Zepbound's cash price is too high
You have other FDA-approved options with lower cash prices on Ro. Ro lists the Wegovy pen at $199 a month for the 0.25 mg and 0.5 mg doses (a limited-time offer for the first two months if you sign up by December 31, 2026; $349 at 1 mg to 2.4 mg), and the starting dose of the Wegovy pill or Foundayo pill at $149 a month, plus membership (Ro pricing). These are different medicines with different dosing and results, so the choice belongs with your prescriber.
Compare Ro's cash GLP-1 options (sponsored affiliate link, opens in a new tab)
Premera members on Medicare: the GLP-1 Bridge
Medicare Part D plans still can't cover drugs for weight loss on their own. Since July 1, 2026, Medicare's GLP-1 Bridge has covered certain weight-loss GLP-1s for eligible people with Part D, including Medicare Advantage plans with drug coverage. The Bridge covers the Zepbound KwikPen, not single-dose pens or vials, along with Wegovy and Foundayo, for $50 for a one-month supply (Medicare.gov: weight-loss drugs).
You may qualify if you're 18 or older, in a lifestyle program, and have:
- A BMI of 35 or higher, or
- A BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher, or
- A BMI of 27 or higher with prediabetes, a past heart attack or stroke, or symptomatic peripheral artery disease
People with type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease aren't eligible for the Bridge because their plan may already cover a GLP-1 for those uses. Bridge approvals run through December 31, 2027. The $50 copay doesn't count toward your Part D deductible or out-of-pocket limit. Full details are in our Medicare GLP-1 Bridge guide.
Federal employees with a Blue Cross Blue Shield FEP plan follow different rules. See does FEHB cover Zepbound. For Medicaid in Washington or Alaska, see GLP-1 Medicaid coverage by state and does Medicaid cover Zepbound.
If Premera denies Zepbound
Read the denial letter first, because the reason decides your next move.
- "Not a covered benefit" means your plan excludes weight-loss drugs. An appeal rarely changes that. Your best options are cash pay or asking your employer to add the benefit at renewal, using our employer request guide.
- "Criteria not met" means the plan covers Zepbound but the request was missing something, such as the 3-month lifestyle trial, a qualifying condition or renewal weight loss. Your doctor can often resend with better records.
More help: plan exclusion vs prior authorization, how to appeal a Zepbound denial, GLP-1 appeal levels explained and external review for a GLP-1 denial.
Your options, side by side
| Route | Who it fits | Monthly cost you'll see | What to do next |
|---|---|---|---|
| Premera coverage with prior authorization | Employer plans that added the benefit | Your copay, possibly $25 with Lilly's card | Prior authorization |
| Cash through Ro | Plans without the benefit, or anyone who wants to skip insurance | $299 to $449 for the KwikPen, plus membership | See Ro's cash prices |
| Medicare GLP-1 Bridge | Eligible people with Part D or Medicare Advantage drug coverage | $50 | Ask your doctor |
| Ask your employer | Plans without the benefit, at renewal time | n/a | Use our employer request guide |
What we actually verified
- Premera Pharmacy Policy 5.01.621, Drugs for Weight Management (effective September 1, 2026, last revised August 11, 2026), read in full for the Zepbound criteria, approval lengths and renewal rules on November 20, 2026.
- Premera's February 2026 Formulary Newsletter on its two GLP-1 coverage pathways.
- Premera's 2026 individual plan letter guide, its 2026 M2 and M4 individual drug lists and its 2027 M1 and M4 individual drug lists.
- Premera's employer drug lists for 2026 (effective November 1, 2026) and 2027 (effective January 1, 2027): A1/A2, B3, B4, E1/E3, E1/E4, E6 and S1/S6, searched for Zepbound, Wegovy and Mounjaro.
- Medicare.gov's GLP-1 Bridge page, Lilly's Zepbound cost page and the Zepbound label.
- Ro's pricing and insurance pages for cash prices, membership and which pens Ro's insurance team handles.
We didn't call Premera, and we can't see your employer's plan. Your benefit booklet and Premera customer service are the final word.
Frequently asked questions
Does Premera cover Zepbound for weight loss?
Only if your employer group chose to add weight-loss drug coverage. Then Zepbound needs prior authorization. Without that benefit, it isn't covered.
What BMI does Premera require for Zepbound?
A BMI of 30 or higher, or 27 or higher with a listed condition such as high blood pressure, high cholesterol or sleep apnea. Some plans set their own BMI threshold.
How long does a Premera Zepbound approval last?
Seven months at first for weight management, then 1-year renewals if you've lost at least 5% of your starting weight. Sleep apnea approvals start at 12 months.
Does Premera cover Zepbound on individual plans?
No. Premera's Washington individual drug lists for 2026 (M2 and M4) and 2027 (M1 and M4) don't list Zepbound or Wegovy. We didn't check Premera's Alaska individual lists.
Does Premera cover Zepbound for sleep apnea?
Premera's policy has sleep apnea criteria: BMI 30 or higher and a sleep study within 12 months showing an AHI of 15 or more. Ask Premera whether your plan includes it.
Does Premera cover Mounjaro instead?
Mounjaro is for type 2 diabetes. Premera covers diabetes GLP-1s across all plans when you have a type 2 diabetes diagnosis and meet its criteria. It isn't a way around a weight-loss exclusion.
How much is Zepbound without insurance in Washington?
On Ro, the Zepbound KwikPen costs $299 to $449 a month depending on dose, plus Ro's membership ($39 the first month, then $74 to $149 a month).
Sources
- Premera: Pharmacy Policy 5.01.621, Drugs for Weight Management (effective September 1, 2026); Formulary Newsletter, February 2026; 2026 individual plan letter guide (all checked November 20, 2026)
- Premera individual drug lists: 2026 Metallic M4, 2026 Metallic M2, 2027 Metallic M4 and 2027 Metallic M1 (checked November 20, 2026)
- Premera 2027 employer drug lists: A1/A2, B3, B4, E1/E3, E1/E4, E6 and S1/S6 (all effective January 1, 2027; checked November 20, 2026)
- Medicare.gov: weight-loss drugs and the GLP-1 Bridge (checked November 20, 2026)
- Lilly: Zepbound cost information and Zepbound prescribing information (revised November 2026; checked November 20, 2026)
- Ro: pricing and insurance (checked November 20, 2026)
Related: does Blue Cross cover Zepbound, does insurance cover Zepbound for weight loss, does Ro take Blue Cross Blue Shield, insurance stopped covering Zepbound, what GLP-1 does BCBS cover.
Do not use Zepbound if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Zepbound has a boxed warning about thyroid C-cell tumors. Tell your prescriber if you're pregnant or planning a pregnancy. Get care right away for severe stomach pain that won't go away (Zepbound prescribing information, revised November 2026).
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.